Practice-Changing Highlights from Chicago 2007
July 2007
- Module I: Breast Cancer Adjuvant/Neoadjuvant Therapy
- Module II: Genitourinary Cancers
- Module III: Supportive Care and Other Advances
- Module IV: Advances in Treatment of Hematologic Malignancies
- Module V: Gastrointestinal Cancers
- Module VI: Lung Cancer
Oncology Nursing, Midlevel Practitioner and Pharmacy Conference 2006: Collaboration for Advancing the Quality of Community Cancer Care
December 2006
- Module I: Novel Therapies in the Treatment of Multiple Myeloma, Lymphoma and Myelodysplastic Syndromes
- Module II: From the Bench to the Bedside: New Drug Highlights
- Module III: At the Crossroads: End of Life Issues in
Cancer Care
- Module IV: Facilitating Communication on Sensitive Issues in Cancer Care
- Module V: On the Horizon of Genetic Research: From Investigator to Reporter to the Public
- Module VI: Women and Cancer: A Focus on Cervical and Ovarian Cancers
- Module VII: Breast Cancer: Application of the Latest Data and Its Implications
- Module VIII: Cancer Comorbidities: Understanding and Managing Toxicity Risks and Late Effects of Treatment
- Module IX: Supportive Care Therapies and Management
- Module X: Optimizing Oral Therapies: What We Need to Know About Delivery and Compliance
- Module XI: Delivering Cancer Care in 2006: Commanding Reimbursement and Regulatory Issues
Hematology Treatment Highlights from Atlanta 2007
February 2008
- Update on Non-Hodgkin’s Lymphoma Treatment: Diffuse Large B-cell Lymphoma
- Therapies for Other Non-Hodgkin’s Lymphomas
- Increasing Options in the Treatment of Multiple Myeloma
- Updates in the Management of MDS
- Erythropoiesis-stimulating Agents: Where are we now?
- Bone Marrow Failure Disorders
- Current Therapeutic Options for Chronic Myelogenous Leukemia
Lung Cancer Care in 2007:
A Multidisciplinary Approach
October 2007
- Module I: Overview of Chemotherapy in Adjuvant NSCLC
- Module II: Update on the Current State of CT Screening
- Module III: Practical Applications of Combined Modalities for the Treatment of Early-Stage NSCLC
Dr. Gregory Kalemkerian
- Module IV: Role and Sequence of Combined Modality Treatment in NSCLC
- Module V: Controversies in the Surgical Management of Early-Stage NSCLC
- Module VI: Early Stage Lung Cancer: Presentation of Challenging Cases and Panel Discussion (Minneapolis, MN; October 6, 2007)
- Module VII: Early Stage Lung Cancer: Presentation of Challenging Cases and Panel Discussion (Houston, TX; October 20, 2007)
- Module VIII: The Biology of Antiangiogenic Agents and Their Use in Metastatic Lung Cancer
- Module IX: First-line Therapy: Beyond Cytotoxic Chemotherapy With the Introduction of Targeted Agents
- Module X: Predictive Indicators for Response in NSCLC
Dr. Craig H. Reynolds
- Module XI: Novel Strategies for Treating Second and Refractory Lung Cancer
- Module XII: Treatment of Metastatic NSCLC: Presentation of Challenging Cases and Panel Discussion (Minneapolis, MN; October
6, 2007)
- Module XIII: Treatment of Metastatic NSCLC: Presentation of Challenging Cases and Panel Discussion (Houston, TX; October
20, 2007)
Trends and Challenges in Community Oncology:
A Focus on Breast Cancer
January 2008
- Evolving strategies in the management of HER2-positive breast
cancer: HER2-directed agents in combination therapy
- Adjuvant therapy in hormone-independent breast cancer
- Optimal management of treatment-related toxicities: bone health,
myelosuppression, emesis, pain, and fatigue
Trends and Challenges in Community Oncology:
A Focus on Lung Cancer
November 2007–January 2008
- Optimizing multimodality therapy for locally advanced NSCLC: selection and dosing
- The role of prognostic and predictive molecular profiles: implications for post-operative systemic therapy in early-stage lung cancer
- Anti-angiogenesis therapies in lung cancer: patient selection for maximal therapeutic efficacy and minimal toxicities
- Treatment options for key clinical and biologic non-small cell lung cancer subpopulations
Healthcare Provider Conference Series 2007:
Collaboration for Advancing the Quality of Community Cancer Care
November 2007–December 2007
- Module I: New Drugs & Indications: Focus on Solid Tumors
- Module II: Recent Developments in Radiation Therapy
- Module III: Current and Emerging Data on Antiangiogenic Agents in the Treatment of Non-Small Cell Lung Cancer
- Module IV: Avoiding Burnout and Coping with Stress in Oncology Practice
- Module V: Reimbursement in the Oncology Practice: 2007 Update and Audience Case Challenges
- Module VI: New Drugs & Indications: Focus on
Hematologic Disorders
- Module VII: Advances in Breast Cancer
- Module VIII: Sexuality Dysfunction in the Cancer Patient: Evidence-Based Management
- Module IX: Diagnosis and Management of Deep Vein Thrombosis and Hemorrhagic Complications in Cancer Patients
- Module X: Pharmacogenomics: Translating Research Concepts into Clinical Practice
- Module XI: Long-term Effects of Cancer and Cancer Treatments: A Focus on Neurocognitive Effects
- Module XII: Current Topics in Survivorship Research: A Critical Discussion of Their Application to Patient Care
- Module XIII: Developing and Implementing Survivorship Planning for Improved Patient Care
- Module XIV: Survivorship Panel Discussion
- Module XV: Long-term Effects of Cancer and Cancer Treatments: A Focus on Cardiovascular Disease
|
|